General and administrative expenses primarily consist of salaries, bonuses, related benefits, and stock-based compensation expense for personnel in executive, finance, and administrative functions; professional fees for legal, consulting, accounting, and audit services; and travel expenses, technology costs, and other allocated expenses.

filing / Aug 4, 2026 / receipt

• depreciation, supplies, travel expenses and other allocated expenses. 27 We recognize research and development expenses in the periods in which they are incurred.

filing / Aug 4, 2026 / receipt

The increase in costs was primarily due to increases in headcount and related expenses. Other Income/(Expense) Other income was $11.3 million for the three months ended June 30, 2026, as compared to $3.3 million for the three months ended June 30, 2025, an increase of $8.0 million.

filing / Aug 4, 2026 / receipt

The increase in costs was primarily due to increases in headcount and related expenses. Other Income/(Expense) Other income was $17.0 million for the six months ended June 30, 2026, as compared to $7.0 million for the six months ended June 30, 2025, an increase of $10.0 million.

filing / Aug 4, 2026 / receipt

We lease administrative office space under operating lease agreements in New York, New York, and Waltham, Massachusetts, which expire in February 2031 and January 2027, respectively.

filing / Aug 4, 2026 / receipt

The new lease agreement will replace our current lease agreement for office space in Waltham, Massachusetts, which is set to expire in January 2027.

filing / Aug 4, 2026 / receipt

General and administrative expenses primarily consist of salaries, bonuses, related benefits, and stock-based compensation expense for personnel in executive, finance, and administrative functions; professional fees for legal, consulting, accounting, and audit services; and travel expenses, technology costs, and other allocated expenses.

filing / May 5, 2026 / receipt

• depreciation, supplies, travel expenses and other allocated expenses. We recognize research and development expenses in the periods in which they are incurred.

filing / May 5, 2026 / receipt

The increase in costs was primarily due to increases in headcount and related expenses. 30 Other Income/(Expense) Other income was $5.7 million for the three months ended March 31, 2026, as compared to $3.7 million for the three months ended March 31, 2025, an increase of $2.0 million.

filing / May 5, 2026 / receipt

We lease administrative office space under operating lease agreements in New York, New York, and Waltham, Massachusetts, which expire in February 2031 and January 2027, respectively.

filing / May 5, 2026 / receipt

Associate Director, Clinical Operations | {"ats": "greenhouse", "city": null, "state": null, "job_id": "4725615005", "remote": true, "category": "other", "function": "operations", "location": "Remote"

company_statement / Aug 19, 2026 / receipt

Associate Director, Clinical Pharmacology and Pharmacometrics | {"ats": "greenhouse", "city": null, "state": null, "job_id": "4725643005", "remote": true, "category": "other", "function": "clinical",

company_statement / Aug 19, 2026 / receipt